SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-082339
Filing Date
2023-03-28
Accepted
2023-03-28 17:21:35
Documents
6
Effectiveness Date
2023-03-28

Document Format Files

Seq Description Document Type Size
1 S-8 d398721ds8.htm S-8 39813
2 EX-5.1 d398721dex51.htm EX-5.1 12172
3 EX-23.1 d398721dex231.htm EX-23.1 1475
4 EX-FILING FEES d398721dexfilingfees.htm EX-FILING FEES 14561
5 GRAPHIC g398721dsp8.jpg GRAPHIC 3925
6 GRAPHIC g398721dsp8a.jpg GRAPHIC 2570
  Complete submission text file 0001193125-23-082339.txt   78273
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270910 | Film No.: 23770711
SIC: 2834 Pharmaceutical Preparations